Madhurima Singh is backing new healthcare businesses, strengthening the pharmaceutical business, and building teams that can take on greater responsibility.
As HCL turns 50, Roshni Nadar Malhotra is steering the group through another reinvention, betting on AI, intellectual property, semiconductors, and faster decision-making.